These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 15083067

  • 21. Effects of pregnane X receptor (NR1I2) and CYP2B6 genetic polymorphisms on the induction of bupropion hydroxylation by rifampin.
    Chung JY, Cho JY, Lim HS, Kim JR, Yu KS, Lim KS, Shin SG, Jang IJ.
    Drug Metab Dispos; 2011 Jan; 39(1):92-7. PubMed ID: 20876786
    [Abstract] [Full Text] [Related]

  • 22. Metabolism of (-)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes.
    Miyazawa M, Gyoubu K.
    Xenobiotica; 2007 Feb; 37(2):194-204. PubMed ID: 17484521
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicity.
    Loboz KK, Gross AS, Williams KM, Liauw WS, Day RO, Blievernicht JK, Zanger UM, McLachlan AJ.
    Clin Pharmacol Ther; 2006 Jul; 80(1):75-84. PubMed ID: 16815319
    [Abstract] [Full Text] [Related]

  • 25. Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion.
    Hesse LM, von Moltke LL, Shader RI, Greenblatt DJ.
    Drug Metab Dispos; 2001 Feb; 29(2):100-2. PubMed ID: 11159797
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation.
    Fan L, Wang JC, Jiang F, Tan ZR, Chen Y, Li Q, Zhang W, Wang G, Lei HP, Hu DL, Wang D, Zhou HH.
    Eur J Clin Pharmacol; 2009 Apr; 65(4):403-9. PubMed ID: 19066872
    [Abstract] [Full Text] [Related]

  • 29. Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro.
    Turpeinen M, Nieminen R, Juntunen T, Taavitsainen P, Raunio H, Pelkonen O.
    Drug Metab Dispos; 2004 Jun; 32(6):626-31. PubMed ID: 15155554
    [Abstract] [Full Text] [Related]

  • 30. CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.
    Lee AM, Jepson C, Hoffmann E, Epstein L, Hawk LW, Lerman C, Tyndale RF.
    Biol Psychiatry; 2007 Sep 15; 62(6):635-41. PubMed ID: 17223085
    [Abstract] [Full Text] [Related]

  • 31. Effects of the selected cytochrome P450 oxidoreductase genetic polymorphisms on cytochrome P450 2B6 activity as measured by bupropion hydroxylation.
    Lv J, Hu L, Zhuo W, Zhang C, Zhou H, Fan L.
    Pharmacogenet Genomics; 2016 Feb 15; 26(2):80-7. PubMed ID: 26580670
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.
    Ring HZ, Valdes AM, Nishita DM, Prasad S, Jacob P, Tyndale RF, Swan GE, Benowitz NL.
    Pharmacogenet Genomics; 2007 Dec 15; 17(12):1007-15. PubMed ID: 18004205
    [Abstract] [Full Text] [Related]

  • 34. Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation.
    Xie HJ, Yasar U, Lundgren S, Griskevicius L, Terelius Y, Hassan M, Rane A.
    Pharmacogenomics J; 2003 Dec 15; 3(1):53-61. PubMed ID: 12629583
    [Abstract] [Full Text] [Related]

  • 35. CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes.
    Ramírez J, Innocenti F, Schuetz EG, Flockhart DA, Relling MV, Santucci R, Ratain MJ.
    Drug Metab Dispos; 2004 Sep 15; 32(9):930-6. PubMed ID: 15319333
    [Abstract] [Full Text] [Related]

  • 36. Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolism.
    Crane AL, Klein K, Zanger UM, Olson JR.
    Toxicology; 2012 Mar 11; 293(1-3):115-122. PubMed ID: 22281205
    [Abstract] [Full Text] [Related]

  • 37. Multiple novel nonsynonymous CYP2B6 gene polymorphisms in Caucasians: demonstration of phenotypic null alleles.
    Lang T, Klein K, Richter T, Zibat A, Kerb R, Eichelbaum M, Schwab M, Zanger UM.
    J Pharmacol Exp Ther; 2004 Oct 11; 311(1):34-43. PubMed ID: 15190123
    [Abstract] [Full Text] [Related]

  • 38. Decreased susceptibility of the cytochrome P450 2B6 variant K262R to inhibition by several clinically important drugs.
    Talakad JC, Kumar S, Halpert JR.
    Drug Metab Dispos; 2009 Mar 11; 37(3):644-50. PubMed ID: 19074527
    [Abstract] [Full Text] [Related]

  • 39. Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression.
    Lamba V, Lamba J, Yasuda K, Strom S, Davila J, Hancock ML, Fackenthal JD, Rogan PK, Ring B, Wrighton SA, Schuetz EG.
    J Pharmacol Exp Ther; 2003 Dec 11; 307(3):906-22. PubMed ID: 14551287
    [Abstract] [Full Text] [Related]

  • 40. Identification and characterization of CYP2B6 cDNA in cynomolgus macaques (Macaca fascicularis).
    Uno Y, Matsuno K, Nakamura C, Utoh M, Yamazaki H.
    J Vet Med Sci; 2009 Dec 11; 71(12):1653-6. PubMed ID: 20046035
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.